Supha Pharmachem Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 5, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	173	734	10,937	2,655	499	158
Market Cap Growth	-88.44%	-93.29%	311.88%	432.56%	214.77%	97.31%
Enterprise Value	11,036	2,497	10,944	2,650	490	216
Last Close Price	0.43	1.27	18.93	4.60	0.86	0.27
PE Ratio	2.30	34.46	33.42	48.94	46.26	32.97
PS Ratio	0.03	0.18	0.27	0.52	0.10	0.18
PB Ratio	0.16	1.67	25.46	25.62	10.10	4.11
P/TBV Ratio	0.16	1.67	25.46	25.62	10.10	4.11
P/FCF Ratio	-	-	-	12.98	4.44	-
P/OCF Ratio	-	-	-	12.95	4.42	-
EV/Sales Ratio	2.09	0.62	0.27	0.52	0.10	0.24
EV/EBITDA Ratio	196.12	203.05	32.72	39.46	27.57	29.91
EV/EBIT Ratio	196.82	209.65	32.77	40.36	28.77	32.62
EV/FCF Ratio	-1.10	-	-	12.95	4.36	-
Debt / Equity Ratio	10.34	26.01	1.34	-	-	2.72
Debt / EBITDA Ratio	193.28	928.04	1.72	-	-	14.55
Net Debt / Equity Ratio	10.33	25.97	1.31	-2.11	-0.29	2.51
Net Debt / EBITDA Ratio	193.04	926.88	1.68	-3.25	-0.81	13.43
Net Debt / FCF Ratio	-1.08	-1.00	-0.76	-1.07	-0.13	-0.94
Asset Turnover	0.28	0.22	2.61	0.74	3.85	4.21
Inventory Turnover	1.81	1.98	56.94	10.83	11.46	46.07
Quick Ratio	0.44	0.46	0.48	0.17	0.35	1.01
Current Ratio	1.07	1.03	1.02	1.01	1.02	1.59
Return on Equity (ROE)	16.22%	4.90%	122.76%	70.92%	24.51%	13.33%
Return on Assets (ROA)	0.19%	0.04%	1.35%	0.60%	0.81%	1.93%
Return on Invested Capital (ROIC)	0.37%	0.09%	29.81%	-	14.11%	5.96%
Return on Capital Employed (ROCE)	5.30%	2.70%	77.70%	63.30%	34.50%	4.60%
Earnings Yield	70.68%	2.90%	2.99%	2.04%	2.16%	3.03%
FCF Yield	-5792.11%	-1546.43%	-6.78%	7.70%	22.53%	-64.72%
Buyback Yield / Dilution	-9.07%	-	-	0.12%	0.03%	-0.14%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.